NASDAQ:GANX | Insider Transactions | Gain Therapeutics, Inc.

GANX Insider Transactions

13 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–13; provenance stays internal.

GANX insiders transaction timeline

PurchaseSale
2021-08-16: 1 purchase — RICHMAN ERIC I2022-05-19: 3 purchases — RICHMAN ERIC I, Calabrese Salvatore2022-05-20: 1 purchase — RICHMAN ERIC I2022-05-25: 1 purchase — RICHMAN ERIC I2023-12-07: 1 sale — Alder Matthias2023-12-21: 1 sale — Alder Matthias2024-03-28: 1 purchase — Riley Jeffrey Scott2024-07-01: 2 purchases — RICHMAN ERIC I2024-08-09: 2 purchases — Mack Gene, Islam Khalid2021-08-162024-08-09
Insider profileRoleDateTransactionSharesPrice
Mack GeneCFO and Interim CEO2024-08-09Purchase14,400.0$1.01
Islam KhalidExecutive Chairman2024-08-09Purchase50,000.0$1.0
RICHMAN ERIC IDirector2024-07-01Purchase12,000.0$1.21
RICHMAN ERIC IDirector2024-07-01Purchase5,000.0$1.23
Riley Jeffrey ScottDirector2024-03-28Purchase30,000.0$3.86
Alder MatthiasChief Executive Officer2023-12-21Sale206.0$2.46
Alder MatthiasChief Executive Officer2023-12-07Sale1,820.0$2.5
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER2022-05-25Purchase2,482.0$2.58
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER2022-05-20Purchase9,256.0$2.83
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER2022-05-19Purchase4,000.0$2.71
Calabrese SalvatoreCHIEF FINANCIAL OFFICER2022-05-19Purchase3,000.0$2.7
Calabrese SalvatoreCHIEF FINANCIAL OFFICER2022-05-19Purchase3,000.0$8,100.0
RICHMAN ERIC IChief Executive Officer2021-08-16Purchase4,922.0$7.87